Richard I Dorin1, Clifford R Qualls, David J Torpy, Ronald M Schrader, Frank K Urban. 1. 1Section of Endocrinology and Metabolism, Medical Service, New Mexico VA Healthcare System, Albuquerque, NM. 2Departments of Medicine and Biochemistry, University of New Mexico School of Medicine, Albuquerque, NM. 3Department of Mathematics and Statistics, Clinical and Translational Science Center, University of New Mexico, Albuquerque, NM. 4Endocrine and Metabolic Unit, Royal Adelaide Hospital, Adelaide, South Australia, Australia. 5Department of Electrical and Computer Engineering, Florida International University, Miami, FL.
Abstract
OBJECTIVE: Cortisol clearance is reduced in sepsis and may contribute to the development of impaired adrenocortical function that is thought to contribute to the pathophysiology of critical illness-related corticosteroid insufficiency. We sought to assess adrenocortical function using computer-assisted numerical modeling methodology to characterize and compare maximal cortisol secretion rate and free cortisol half-life in septic shock, sepsis, and healthy control subjects. DESIGN: Post hoc analysis of previously published total cortisol, free cortisol, corticosteroid-binding globulin, and albumin concentration data. SETTING: Single academic medical center. PATIENTS: Subjects included septic shock (n = 45), sepsis (n = 25), and healthy controls (n = 10). INTERVENTIONS: I.v. cosyntropin (250 μg). MEASUREMENTS AND MAIN RESULTS: Solutions for maximal cortisol secretion rate and free cortisol half-life were obtained by least squares solution of simultaneous, nonlinear differential equations that account for free cortisol appearance and elimination as well as reversible binding to corticosteroid-binding globulin and albumin. Maximal cortisol secretion rate was significantly greater in septic shock (0.83 nM/s [0.44, 1.58 nM/s] reported as median [lower quartile, upper quartile]) compared with sepsis (0.51 nM/s [0.36, 0.62 nM/s]; p = 0.007) and controls (0.49 nM/s [0.42, 0.62 nM/s]; p = 0.04). The variance of maximal cortisol secretion rate in septic shock was also greater than that of sepsis or control groups (F test, p < 0.001). Free cortisol half-life was significantly increased in septic shock (4.6 min [2.2, 6.3 min]) and sepsis (3.0 min [2.3, 4.8 min] when compared with controls (2.0 min [1.2, 2.6 min]) (both p < 0.004). CONCLUSIONS: Results obtained by numerical modeling are consistent with comparable measures obtained by the gold standard stable isotope dilution method. Septic shock is associated with generally not only higher levels but also greater variance of maximal cortisol secretion rate when compared with control and sepsis groups. Additional studies would be needed to determine whether assessment of cortisol kinetic parameters such as maximal cortisol secretion rate and free cortisol half-life is useful in the diagnosis or management of critical illness-related corticosteroid insufficiency.
OBJECTIVE:Cortisol clearance is reduced in sepsis and may contribute to the development of impaired adrenocortical function that is thought to contribute to the pathophysiology of critical illness-related corticosteroid insufficiency. We sought to assess adrenocortical function using computer-assisted numerical modeling methodology to characterize and compare maximal cortisol secretion rate and free cortisol half-life in septic shock, sepsis, and healthy control subjects. DESIGN: Post hoc analysis of previously published total cortisol, free cortisol, corticosteroid-binding globulin, and albumin concentration data. SETTING: Single academic medical center. PATIENTS: Subjects included septic shock (n = 45), sepsis (n = 25), and healthy controls (n = 10). INTERVENTIONS: I.v. cosyntropin (250 μg). MEASUREMENTS AND MAIN RESULTS: Solutions for maximal cortisol secretion rate and free cortisol half-life were obtained by least squares solution of simultaneous, nonlinear differential equations that account for free cortisol appearance and elimination as well as reversible binding to corticosteroid-binding globulin and albumin. Maximal cortisol secretion rate was significantly greater in septic shock (0.83 nM/s [0.44, 1.58 nM/s] reported as median [lower quartile, upper quartile]) compared with sepsis (0.51 nM/s [0.36, 0.62 nM/s]; p = 0.007) and controls (0.49 nM/s [0.42, 0.62 nM/s]; p = 0.04). The variance of maximal cortisol secretion rate in septic shock was also greater than that of sepsis or control groups (F test, p < 0.001). Free cortisol half-life was significantly increased in septic shock (4.6 min [2.2, 6.3 min]) and sepsis (3.0 min [2.3, 4.8 min] when compared with controls (2.0 min [1.2, 2.6 min]) (both p < 0.004). CONCLUSIONS: Results obtained by numerical modeling are consistent with comparable measures obtained by the gold standard stable isotope dilution method. Septic shock is associated with generally not only higher levels but also greater variance of maximal cortisol secretion rate when compared with control and sepsis groups. Additional studies would be needed to determine whether assessment of cortisol kinetic parameters such as maximal cortisol secretion rate and free cortisol half-life is useful in the diagnosis or management of critical illness-related corticosteroid insufficiency.
Authors: Eva Boonen; Philippe Meersseman; Hilke Vervenne; Geert Meyfroidt; Fabian Guïza; Pieter J Wouters; Johannes D Veldhuis; Greet Van den Berghe Journal: Am J Physiol Endocrinol Metab Date: 2014-02-25 Impact factor: 4.310
Authors: Yvonne M Ulrich-Lai; Helmer F Figueiredo; Michelle M Ostrander; Dennis C Choi; William C Engeland; James P Herman Journal: Am J Physiol Endocrinol Metab Date: 2006-06-13 Impact factor: 4.310
Authors: J T Ho; H Al-Musalhi; M J Chapman; T Quach; P D Thomas; C J Bagley; J G Lewis; D J Torpy Journal: J Clin Endocrinol Metab Date: 2005-11-01 Impact factor: 5.958
Authors: Paul E Marik; Stephen M Pastores; Djillali Annane; G Umberto Meduri; Charles L Sprung; Wiebke Arlt; Didier Keh; Josef Briegel; Albertus Beishuizen; Ioanna Dimopoulou; Stylianos Tsagarakis; Mervyn Singer; George P Chrousos; Gary Zaloga; Faran Bokhari; Michael Vogeser Journal: Crit Care Med Date: 2008-06 Impact factor: 7.598
Authors: Bala Venkatesh; Jeremy Cohen; Ingrid Hickman; Janelle Nisbet; Peter Thomas; Gregory Ward; Jonathan Hall; John Prins Journal: Intensive Care Med Date: 2007-06-09 Impact factor: 17.440
Authors: Richard I Dorin; Hemanth K Pai; Jui T Ho; John G Lewis; David J Torpy; Frank K Urban; Clifford R Qualls Journal: Clin Biochem Date: 2008-10-17 Impact factor: 3.281
Authors: Christina M Lovato; Thierry Thévenot; Sophie Borot; Vincent Di Martino; Clifford R Qualls; Frank K Urban; Richard I Dorin Journal: JHEP Rep Date: 2021-03-19
Authors: Richard I Dorin; Zhi George Qiao; Matthew Bouchonville; Clifford R Qualls; Ronald M Schrader; Frank K Urban Journal: J Endocr Soc Date: 2017-06-01
Authors: Alessandro Prete; Angela E Taylor; Irina Bancos; David J Smith; Mark A Foster; Sibylle Kohler; Violet Fazal-Sanderson; John Komninos; Donna M O'Neil; Dimitra A Vassiliadi; Christopher J Mowatt; Radu Mihai; Joanne L Fallowfield; Djillali Annane; Janet M Lord; Brian G Keevil; John A H Wass; Niki Karavitaki; Wiebke Arlt Journal: J Clin Endocrinol Metab Date: 2021-01-01 Impact factor: 5.958